Skip main navigation
Close Drawer MenuOpen Drawer Menu
APA Publishing Logo

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
Preliminary ProgramFull Access

Preliminary Program: Wednesday, May 18

Published Online:18 Feb 2011https://doi.org/10.1176/pn.46.4.psychnews_46_4_46_1

7 a.m.-8:30 a.m.

Scientific and Clinical Reports

SCR29. Mood Disorders 2

  • 97. Decrease in Depression Predicts Longer Survival With Metastatic Breast Cancer David Spiegel, M.D.

  • 98. Efficacy of Valproic Acid, Lithium Carbonate, and Carbamazepine in Maintenance Phase of Bipolar Disorder: A Naturalistic Study Eric Peselow, M.D.

  • 99. Assessment of a Biomarker Panel for Major Depressive Disorder in a Community-Based Study Perry Renshaw, M.D., Ph.D.

  • 100. L-Methylfolate Augmentation of Selective Serotonin Reuptake Inhibitors for Major Depressive Disorder: Results of Two Randomized, Double-Blind Trials George Papakostas, M.D.

SCR30. Personality Disorders 2

  • 101. Implementing STEPPS in Iowa Prisons Donald W. Black, M.D.

  • 102. Schema Therapy: A Comprehensive Treatment for Borderline Personality Disorder Heather Fretwell, M.D.

  • 103. Smoking in Patients With Borderline Personality Disorder Frances Frankenburg, M.D.

  • 104. Dual Challenge in the Field: How to Identify and Treat Patients With Comorbid Diagnoses of Bipolar and Borderline Personality Disorders Bernadette Grosjean, M.D.

Workshops

W107. Assessing and Treating Alcohol Use Disorders in Psychiatric PracticeChairs: Mark Willenbring, M.D., Robert Huebner, Ph.D.

W108. Psychiatric Injury and the Law: PTSD Gone Wild?Chairs: Landy F. Sparr, M.D., M.A., Charles Scott, M.D.

W109. Successful Career Planning for WomenSupported by APA Women's Caucus; Chair: Gail E. Robinson, M.D.

W110. Developing a Career in Child PsychiatryChair: Ara Anspikian, M.D.

W111. The Accessible Psychiatry Project: The Public Face of Psychiatry in New MediaChairs: Steven R. Daviss, M.D., Dinah Miller, M.D.

W112. The Customer Is Always Wrong: The Inverse Correlation Between Patient Requests and Services Delivered in Emergency Psychiatric ServicesChairs: Kenneth M. Certa, M.D., Jessica Mosier, M.D.

8 a.m.-11 a.m.

Media Workshop

MW9. Madly GiftedAPA Council on Communications; Chairs: Nubia G. Lluberes, M.D., Assim Shah, M.D., Niberca Polo, M.A.

Symposia

S85. Treating Behavioral Disturbances in Dementia in the Era of Black-Box Warnings

  • Treating Behavioral Disturbances in Dementia in the Era of Black-Box Warnings Sunanda Muralee, M.D.

S86. Stigmatization of Psychiatry and Psychiatrists: An International Perspective

  • Stigmatization of Mental Disorders Norman Sartorius, M.D., Ph.D.

  • Improvement of Value of Psychiatry Tsuyoshi Akiyama, M.D., Ph.D.

  • Stigmatizing Psychiatry and Psychiatrists: The Scope of the Problem Wolfgang Gaebel, M.D.

  • Stigmatization and the Media Allan Tasman, M.D.

S87. Predictors of Disease Vulnerability and Treatment Response: Personalized Medicine in Psychiatry

  • Personalized Medicine: Depression Charles B. Nemeroff, M.D., Ph.D.

  • Personalized Medicine: Psychotic Major Depression Alan F. Schatzberg, M.D.

  • Using fMRI to Predict Treatment Response in Patients With GAD and Depression Ned Kalin, M.D.

  • Personalized Medicine in Psychiatry: Alzheimer's Disease Claes Wahlestedt, M.D., Ph.D.

  • Personalized Medicine in Psychiatry: Emergent Therapeutic Advances in Schizophrenia Peter Buckley, M.D.

S88. Cannabinoid Medicine: Discovery, Evolution, and Status in 2011

  • Cannabis: A Commonwealth Medicinal Plant, Long Suppressed, Now at Risk of Monopolization Sunil Aggarwal, M.D., Ph.D.

  • Problems in Current Policies Toward Marijuana Usage Ronald Abramson, M.D.

  • Navigating the Three Streams of Medicinal Cannabis Research in North America David Ostrow, M.D., Ph.D.

  • Navigating the Three Streams of Medicinal Cannabis Research in North America Mark Ware, M.D., M.Sc.

  • An Illustrative Discussion of Quality, Pertinence, Reliability, and Usefulness of Medical Literature Relevant to the Concepts Presented Above Lawrence K. Richards, M.D.

  • Deconstructing Marijuana Abuse, Dependence, and Medication John Halpern, M.D.

S89. Depression and Disparity: AGlobal Perspective

  • Overcoming Disparities in Depression Management Jurgen Unutzer, M.D., M.P.H.

  • Lessons Learned From Two Randomized Clinical Trials of Interpersonal Psychotherapy in Uganda Helen Verdeli, Ph.D.

  • Adaptation of a Depression Treatment Intervention for HIV patients in Cameroon Bradley N. Gaynes, M.D., M.P.H.

  • Facilitators to Improve Mental Health Care in Underserved Countries Wei Jiang, M.D.

S90. Recent Advances in the Cross-Cultural, Ethnic, and Ethnopsychopharmacological Aspects of Mood Disorders

  • Ethnopsychopharmacology Update David Henderson, M.D.

  • Psychiatric Management of Hispanic Patients: Cross-Cultural Issues and Ethnopsychopharmacology David Mischoulon, M.D., Ph.D.

  • Culturally Sensitive Treatment of Depressed Chinese Americans in Primary Care Albert Yeung, M.D., Sc.D.

  • Management of Mood and Anxiety Disorders in the Asian-Indian Population: An Update on Cross-Cultural Factors and Psychopharmacological Considerations Rajesh Parikh, M.D.

  • A Cultural Perspective on the Diagnosis and Treatment of Mood Disorders in Women: An Update Shamsah Sonawalla, M.D.

S91. Why Do Antidepressant Trials Fail?

  • Role of Placebo in Antidepressant Clinical Trials Arif Khan, M.D.

  • Patient Expectancy in Antidepressant Clinical Trials Bret Rutherford, M.D.

  • How Do the Odds of Receiving a Placebo Impact Antidepressant Trial Results? Mark Sinyor, M.D., M.Sc.

  • Are There Alternative Trial Designs? David Mischoulon, M.D., Ph.D.

  • Clinical Trial Procedures That Contribute to the Placebo Response Walter Brown, M.D.

S92. Mental Health and Legal Perspectives of Same-Sex Civil Marriage in the United StatesAssociation of Gay and Lesbian Psychiatrists

  • How APA's 1973 Decision to Remove Homosexuality From the DSM Contributed to Today's Culture Wars About Marriage Equality Jack Drescher, M.D.

  • A Mental Health Research Perspective on Marital Rights and Civil Marriage for Lesbians and Gay Men Robert Kertzner, M.D.

  • Advocating for Marriage Equality Through Op-Eds Mary Barber, M.D.

  • Marriage Plans Interrupted and Then Fulfilled: The Impact on a Family Ellen Haller, M.D.

S93. Activated Inflammatory Response System in Patients With Psychiatric Disorders Across the Lifespan

  • Is There an Increase in the Inflammatory Response System in Patients With Substance Dependence? Albana Dreshaj, D.O.

  • Cerebral Activation of the Mononuclear Phagocyte System in Depression and Schizophrenia: Postmortem Studies on the Role of Microglia Johann Steiner, M.D.

  • Serum S100B: A Potential Biomarker for Suicidality in Adolescents? Tatiana Falcone, M.D.

  • Monocyte and T Cell Activation in Psychiatric and Prepsychiatric Disease Roosmarijn Drexhage, M.D.

S94. Suicide and Anxiety: What Are the Risks?

  • Lethality of Suicide Attempts Among Individuals With Anxiety Disorders in a Nationally Representative Sample James Bolton, M.D.

  • Panic as an Independent Risk Factor for Suicide Attempt in Depressive Illness: Findings From the NESARC Survey Zimri Yaseen, M.D., Curren Katz, Ed.M.

  • The Course of the Suicidal Process: Duration and Choice of Method Eberhard Deisenhammer, M.D.

S95. The Status of Psychiatric Research in the Arab WorldArab American Psychiatric Association

  • Psychiatric Research in the Arab World: Where to Go From Here? Ossama T. Osman, M.D., M.B.A.

  • A Closer Look at the Psychiatric Research in Egypt Afaf Khalil, M.D.

  • Substance Dependence Research in the Arab World: The Current Situation and Future Development Hesham Elarabi, Pharm.D., M.S.

S96. Psychiatric and Somatic Symptoms Closely Entwined

  • GHB Detoxification Demands a Multidisciplinary Approach Selene Veerman, M.D.

  • Fatal Lithium Intoxication Maartje de Graaf, M.D.

  • Severe Mental Disorders and an Atypically Presented Acute Physical Illness: A Challenge for the Psychiatrist Willemijn Noom, M.D.

  • From Psychosis to Relief of Conversion Disorder Nathalie den Ouden, M.D.

9 a.m.-10:30 a.m.

Scientific and Clinical Reports

SCR 31. Attention Spectrum Disorders

  • 105. Guanfacine Extended Release Coadministered With Psychostimulants: Overall, Morning, and Evening Attention-Deficit/Hyperactivity Disorder Assessments Timothy Wilens, M.D.

  • 106. Family Risk for Deficient Emotional Self-Regulation and Adult Attention Deficit/Hyperactivity Disorder Craig Surman, M.D.

  • 107. Efficacy of Reboxetine in Adults With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo Controlled Clinical Trial Mehdi Tehranidoost, M.D.

  • 108. Assessment of Cognitive Change in Adults and Children With Attention-Deficit Disorder During Medication Treatment Kathleen Decker, M.D.

Workshops

W113. Do You Hear What I Hear? How to Utilize Technology to Promote Lifelong LearningChair: Peter S. Martin, M.D., M.P.H.

W114. Collaborating for Change: DBT/MBT Psychoeducation Can Develop Family Members of People With Borderline Personality Disorder as Clinical AlliesChairs: Valerie Porr, M.A., Linda A. Dimeff, Ph.D.

W115. Stories From the Front Lines: Psychiatrists' Experiences in the Integration of Primary Care and Behavioral HealthChair: Ruth S. Shim, M.D., M.P.H.

W116. Substance Abuse and HIV/AIDS: Women's PerspectiveChairs: Michelle Primeau, M.D., Pedro Ruiz, M.D.

W117. A Collaborative Approach to Interdisciplinary Treatment PlanningChair: Jaskanwar Batra, M.D.

W118. Somatizing: What Every Psychiatrist Needs to KnowChair: Jon J.D. Davine, M.D.

10 a.m.-11:30 a.m.

Lecture

L26. Genomics: Unpicking the Gordian Knot of Psychiatry?Chair: Michael M. Owen, Ph.D., M.Sc.

11 a.m.-12:30 p.m.

Workshops

W119. Addressing Diabetes and Cardiometabolic Risk in Low-Resource Community Psychiatry Settings: Tools to Tap Into MotivationChairs: Jeanie Tse, M.D., Elisa Chow, Ph.D.

W120. Anishinaabe, Ojibwe, Healing Practices, and Guiding Life PrinciplesChair: Robert C. Palmer, M.D.

W121. Promoting Improved Integration: An Examination of Collaborative Health Care ModelsAPA Council on Advocacy and Government Relations; Chair: Peter S. Martin, M.D., M.P.H.

W122. The Role of Psychiatrists Supporting the U.S. Embassy Employees During the Haiti Earthquake: Perspectives From Department of State Mental Health ServicesChair: Panakkal David, M.D.